Across Britain, a quiet paradox is unfolding: growing numbers of people are seeking formal ADHD diagnoses and then declining the treatment that would follow. Half of diagnosed children never pursue medication or therapy, and a similar pattern is emerging among adults — suggesting that for many, the label itself has become the destination. Psychiatrists and public health voices are grappling with what this reveals: not simply a system stretched thin by demand, but a deeper cultural moment in which a neurological condition has begun to function as a form of identity, shaped as much by social lon
ADHD diagnosis surge raises questions about identity versus disorder
A condition becoming an identity rather than an ailment
Mark
Why would someone seek a diagnosis and then refuse treatment? That seems contradictory.
Mimi
Because the diagnosis itself has become valuable in ways treatment isn't. It explains struggles, it offers community, it can shift how people see themselves. Treatment is harder—it's medication with side effects, it's admitting you need help. The label alone can feel like enough.
Mark
So the private providers are essentially selling identity?
Mimi
Not intentionally, maybe. But when you're a business and diagnosis is your product, and half your customers don't buy the next step, you're not incentivized to ask hard questions about whether they actually need it.
Mark
Adamou says ADHD is both real and constructed. How does that work?
Mimi
The brain differences are real. The research is solid. But what counts as ADHD—where you draw the line between difference and disorder—that's been redrawn so many times it's become almost meaningless. Real condition, inflated category.
Mark
Is the documentary saying we should stop diagnosing ADHD?
Mimi
Not exactly. It's saying schools and workplaces should change to accommodate different minds, rather than assuming the mind needs to change to fit the system. That's a different question than whether ADHD exists.
Mark
But doesn't that leave people without support who genuinely need it?
Mimi
That's the real fear. If you blur the line too much, you create what Adamou calls a double stigma—people with real ADHD get dismissed as just seeking identity. The system breaks for everyone.
Le Pouls
- Half of children diagnosed with ADHD never pursue treatment, signaling that the diagnosis itself — not the care it unlocks — has become the point for a growing number of patients.
- A flood of low-quality private assessment providers is fueling the surge, creating a profit-driven pipeline that leaves patients with labels but little clinical follow-through, and NHS doctors fielding complaints about assessments they consider inadequate.
- Some patients are seeking low-dose stimulants not as treatment but as cognitive enhancement, raising an uncomfortable question the system has not yet openly confronted: whether Britain is quietly augmenting productivity through unacknowledged pharmaceutical means.
- A Channel 4 documentary and senior psychiatrists are pushing back hard, arguing that ADHD risks medicalizing ordinary human variation — but private providers warn that dismissing the condition trivializes real suffering and deepens inequality.
- The system sits at an unresolved crossroads: NHS waiting lists stretch toward a decade in some trusts, private care is inconsistent, and no consensus exists on whether the answer is structural reform, tighter standards, or a fundamental rethinking of what ADHD means.
Across Britain, a quiet paradox is unfolding: growing numbers of people are seeking formal ADHD diagnoses and then declining the treatment that would follow. Half of diagnosed children never pursue medication or therapy, and a similar pattern is emerging among adults — suggesting that for many, the label itself has become the destination. Psychiatrists and public health voices are grappling with what this reveals: not simply a system stretched thin by demand, but a deeper cultural moment in which a neurological condition has begun to function as a form of identity, shaped as much by social longing as by clinical need.
Something unusual is happening in British mental health care. People are pursuing ADHD diagnoses — and then stopping. They receive the formal label and walk away from treatment. Half of children diagnosed with ADHD never go on to take medication or engage in therapy. The same pattern is appearing in adults. For psychiatrists watching this unfold, it points to something stranger than overdiagnosis: a medical condition quietly becoming an identity.
Dr Marios Adamou, founder of the UK Adult ADHD Network, traces much of this to the explosion of private assessment providers, many of poor quality, who diagnose patients and leave them without meaningful follow-up. The result is a wave of complaints against NHS doctors who reject these private assessments as insufficient. Adamou sees a market problem wearing a medical mask. No other condition in Britain, he notes, is so dominated by private provision — and when diagnosis becomes a commodity tied to stimulant prescriptions, the incentives distort everything around them. Yet he resists a simple verdict. ADHD is both real and constructed, he argues — neurologically grounded, but stretched so far in recent years that its meaning has begun to blur. Some patients, he observes, seek low doses of stimulants not for treatment but for sharper focus and greater productivity. The country, he suggests, has not had an honest public debate about whether it wants to cognitively augment itself through amphetamines.
A Channel 4 documentary airing in August 2026 sharpens the challenge. Presented by NHS psychiatrist Dr Max Pemberton, it frames ADHD as a social construct and argues that schools should adapt to children rather than medicating them toward conformity. Prof Dinesh Bhugra, former head of the Royal College of Psychiatrists, shares the unease — warning that clinicians risk medicalizing normal human variation, and that the ADHD label now carries a social currency that may be driving demand as much as genuine clinical need.
The private sector responds firmly. Jessica Lister of Care ADHD argues that dismissing the condition as constructed trivializes real harm and entrenches inequality across education, employment, and justice. Her colleague Mark Pattison points to NHS trusts where children wait nearly a decade for assessment, calling that a failure no provider type can claim immunity from. The real question, he insists, is not whether ADHD exists — it is whether a fragmented, overstretched, and profit-shaped system can tell the difference between genuine disorder and identity-seeking, and whether it can serve either honestly.
A peculiar inversion is happening in British mental health care. People are now seeking ADHD diagnoses—the formal stamp of a neurological condition—and then stopping. They get the label and walk away from treatment. Half of children diagnosed with ADHD never pursue medication or therapy afterward. The same pattern is emerging in adults. This shift has alarmed psychiatrists, who are watching something stranger than simple overdiagnosis unfold: a condition becoming an identity rather than an ailment.
Dr Marios Adamou, who founded the UK Adult ADHD Network, has observed this directly in his clinic. He traces much of it to the explosion of private assessment providers—many of poor quality—who diagnose people and then leave them believing they need treatment they never actually seek. The result is a cascade of complaints against NHS doctors who reject these assessments as inadequate. Adamou sees a market problem masquerading as a medical one. "Most of the assessment in the UK is now provided by the private sector," he said. "I don't think there's any other medical condition where the private sector provides as much care." When diagnosis becomes a commodity, when it attracts stimulant medications, when profit sits at the center of the system, the incentives shift. The condition itself begins to mean something different than it did before.
Yet Adamou resists a simple answer. He argues ADHD is both real and constructed—a genuine brain disorder with solid neurological research behind it, but one whose definition has been stretched so far it risks becoming meaningless. The diagnostic criteria have undergone rigorous scientific validation, he notes. But in recent years, the concept has expanded so dramatically that it now encompasses things it didn't before. Some patients seek only low doses of stimulants, not for treatment but for cognitive enhancement. "A lot of people would benefit from having amphetamines," Adamou observed. "You feel better, you can focus better, you can do more. But there hasn't been a debate that this country should be cognitively augmented to increase productivity with stimulants." The question beneath the question is why people feel they can identify with ADHD at all. "They are manifestations of a societal problem," he suggested.
A new Channel 4 documentary, airing in August 2026 and titled "The Great ADHD Myth?," pushes the argument further. Presented by NHS psychiatrist Dr Max Pemberton, it concludes that ADHD functions as a social construct rather than a medical condition—that schools should adapt to accommodate a wider range of children rather than medicating them into conformity. Prof Dinesh Bhugra, former head of the Royal College of Psychiatrists, echoes the concern. He worries that clinicians and society are medicalizing normal human variation because it grants power to doctors and offers people a label that carries social cachet. "The question is why now, and why this?" he asks. "What is it providing?" He sees an American import: the insurance-driven, checklist-style diagnostic approach that treats health as a commodity to be bought and sold.
But the private sector pushes back. Jessica Lister, clinical director at Care ADHD, warns that dismissing ADHD as mere social construction trivializes a real clinical condition and perpetuates inequalities in education, employment, and justice. The actual problem, she argues, is not whether ADHD exists but whether systems respond early, consistently, and fairly enough. Mark Pattison, Care ADHD's chief executive, points out that some NHS trusts have children waiting a decade for assessment—"that's not safe care, whoever provides it." He acknowledges that some private providers fall short, but insists that standards should apply universally, not just to the private sector. The debate, then, is not whether ADHD is real. It is whether the current system—fragmented, profit-driven, and overwhelmed—can distinguish between genuine disorder and identity-seeking, and whether it can serve either well.
Citations marquantes
Most of the assessment in the UK is now provided by the private sector. I don't think there's any other medical condition where the private sector provides as much care.— Dr Marios Adamou, founder of the UK Adult ADHD Network
Dismissing ADHD as a social construct doesn't just trivialise an established clinical condition – it perpetuates the inequalities faced by people with ADHD across education, health, employment and the justice system.— Jessica Lister, clinical director at Care ADHD
Envie de l'histoire complète ?
Lire l'original sur The Guardian ↗
Health & Medicine